The Clinical Use and Performance of High-Sensitivity Troponin Assays

Overcoming Challenges in Implementation

Tuesday, August 6
7-8:30 a.m.
Anaheim Marriott, Platinum Ballroom 1

Register Today

Please note that registration for this event is separate from registration for the AACC Annual Scientific Meeting. Limited seating is available and complimentary breakfast will be provided.

Session Description

This program will discuss the processes that lead to successful high-sensitivity troponin implementation, and the challenges that laboratory professionals may face within their institution when converting.

Institutional assay conversion from contemporary troponin to high-sensitivity troponin markers is a complex process that should be well planned. As laboratories are considering this change, they will need to collaborate with their clinical colleagues to ensure that their challenges are addressed, and patient safety is preserved. In this workshop, we will discuss conversion experiences from outside the U.S., suggest some processes that can enable smooth migration, and provide the clinical perspective for awareness, along with some possible challenges and how to overcome them.

What You Will Learn

  • Articulate the organizational and technical questions labs should plan for as they consider adoption of high-sensitivity troponin in their institution
  • Explain the clinical perspectives that guide the approach taken by the emergency department and cardiology communities in their institutions
  • Describe the processes and approaches taken by others that have successfully completed the migration


Maria Rubini-Gimenez, MD (Session Chair)
Universitätsspital Basel
Department of Cardiology
Basel, Switzerland

  • Review of guidelines-approved timepoints

Robert H. Christenson, PhD
Professor of Pathology 
Professor of Medical and Research Technology
University of Maryland School of Medicine
Baltimore, MD

  • High Sensitivity Troponin: Why Convert?

Lori Daniels, MD, MAS, FACC, FAHA
Director, Coronary Care Unit
Professor of Medicine
UC San Diego Health
La Jolla, CA

  • Implementing Experiences

Bryn E. Mumma, MD, MAS
Assistant Professor
Department of Emergency Medicine
University of California Davis School of Medicine
Sacramento, CA

  • Implementing Experiences

Nam Tran, PhD, HCLD(ABB), FACB
Associate Clinical Professor
Director of Clinical Chemistry
Point-of-Care Testing and SARC Sections
Pathology and Laboratory Medicine
University of California Davis School of Medicine
Sacramento, CA

  • Implementing Experiences
  • Validation Planning
    • Analytical vs. Clinical
    • Analysis Planning

ACCENT® Accreditation

AACC designates this activity for a maximum of 1.5 ACCENT® credit hours towards the AACC Clinical Chemist’s Recognition Award. AACC is an approved provider of continuing education (CE) for clinical laboratory scientists licensed in states that require documentation of CE, including California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, Tennessee, and West Virginia. ACCENT® credit is also recognized by several organizations: AAB, ABCC, ACS, AMT, ASCLS, ASCP, ASM, CAP, IFCC, and NRCC.

Sponsored By

Ortho Clinical Diagnostics Logo

Roche Logo